130 related articles for article (PubMed ID: 26528899)
1. Identification and proportion of the enantiomers of the antihypertensive drug chlortalidone in its Form II by high quality single-crystal X-ray diffraction data.
Santos LM; Santos OMM; Mendes PF; Rosa IML; Silva CCD; Bonfilio R; de Araujo MB; Boralli VB; Doriguetto AC; Martins FT
J Pharm Biomed Anal; 2016 Jan; 118():101-104. PubMed ID: 26528899
[TBL] [Abstract][Full Text] [Related]
2. Analysis of chlorthalidone polymorphs in raw materials and tablets and the effect of forms I and II on the dissolution properties of drug products.
Bonfilio R; Leal JS; Santos OM; Pereira GR; Doriguetto AC; de Araújo MB
J Pharm Biomed Anal; 2014 Jan; 88():562-70. PubMed ID: 24216278
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of preferential enrichment, an unusual enantiomeric resolution phenomenon caused by polymorphic transition during crystallization of mixed crystals composed of two enantiomers.
Tamura R; Fujimoto D; Lepp Z; Misaki K; Miura H; Takahashi H; Ushio T; Nakai T; Hirotsu K
J Am Chem Soc; 2002 Nov; 124(44):13139-53. PubMed ID: 12405843
[TBL] [Abstract][Full Text] [Related]
4. Impact of molecular flexibility on double polymorphism, solid solutions and chiral discrimination during crystallization of diprophylline enantiomers.
Brandel C; Amharar Y; Rollinger JM; Griesser UJ; Cartigny Y; Petit S; Coquerel G
Mol Pharm; 2013 Oct; 10(10):3850-61. PubMed ID: 23984951
[TBL] [Abstract][Full Text] [Related]
5. Phase quantification of antihypertensive drugs - Chlorthalidone, Hydrochlorothiazide, Losartan and combinations, Losartan/Chlorthalidone and Losartan/Hydrochlorothiazide - by the Rietveld method.
Reis do Carmo W; Ferreira FF; Diniz R
J Pharm Biomed Anal; 2014 Jan; 88():152-6. PubMed ID: 24055851
[TBL] [Abstract][Full Text] [Related]
6. The control of impurities in chlortalidone using a reversed-phase stationary phase.
Douville V; Keller E; Lambertz K; Lodi A; Miller JH
Pharmeur Sci Notes; 2005 Aug; 2005(1):5-10. PubMed ID: 17687887
[TBL] [Abstract][Full Text] [Related]
7. Formation of solid solutions between racemic and enantiomeric citalopram oxalate.
de Diego HL; Bond AD; Dancer RJ
Chirality; 2011 May; 23(5):408-16. PubMed ID: 21472783
[TBL] [Abstract][Full Text] [Related]
8. Solubility, metastable zone width, and racemic characterization of propranolol hydrochloride.
Wang X; Wang XJ; Ching CB
Chirality; 2002 May; 14(4):318-24. PubMed ID: 11968072
[TBL] [Abstract][Full Text] [Related]
9. Formation of the racemic compound of ephedrine base from a physical mixture of its enantiomers in the solid, liquid, solution, or vapor state.
Duddu SP; Grant DJ
Pharm Res; 1992 Aug; 9(8):1083-91. PubMed ID: 1409382
[TBL] [Abstract][Full Text] [Related]
10. Chemometrics-assisted simultaneous determination of atenolol and chlorthalidone in synthetic binary mixtures and pharmaceutical dosage forms.
Ferraro MC; Castellano PM; Kaufman TS
Anal Bioanal Chem; 2003 Dec; 377(7-8):1159-64. PubMed ID: 12955392
[TBL] [Abstract][Full Text] [Related]
11. Enabling Direct Preferential Crystallization in a Stable Racemic Compound System.
Harfouche LC; Brandel C; Cartigny Y; Ter Horst JH; Coquerel G; Petit S
Mol Pharm; 2019 Nov; 16(11):4670-4676. PubMed ID: 31545612
[TBL] [Abstract][Full Text] [Related]
12. [Physicochemical properties of suplatast tosilate racemate and enantiomers].
Ushio T; Endo K; Yamamoto K
Yakugaku Zasshi; 1996 Nov; 116(11):866-75. PubMed ID: 8981830
[TBL] [Abstract][Full Text] [Related]
13. Investigation of the Binary System of Proxyphylline Enantiomers: Structural Resolution and Phase Diagram Determination.
Pinetre C; Harfouche L; Brandel C; Bendeif EE; Sanselme M; Cartigny Y; Couvrat N; Dupray V
Mol Pharm; 2024 Feb; 21(2):845-853. PubMed ID: 38134443
[TBL] [Abstract][Full Text] [Related]
14. The structure of a centrosymmetric protein crystal.
Zawadzke LE; Berg JM
Proteins; 1993 Jul; 16(3):301-5. PubMed ID: 8346193
[TBL] [Abstract][Full Text] [Related]
15. Discovery of a solid solution of enantiomers in a racemate-forming system by seeding.
Huang J; Chen S; Guzei IA; Yu L
J Am Chem Soc; 2006 Sep; 128(36):11985-92. PubMed ID: 16953640
[TBL] [Abstract][Full Text] [Related]
16. (R)-(-)- and (S)-(+)-Synadenol: synthesis, absolute configuration, and enantioselectivity of antiviral effect.
Qiu YL; Hempel A; Camerman N; Camerman A; Geiser F; Ptak RG; Breitenbach JM; Kira T; Li L; Gullen E; Cheng YC; Drach JC; Zemlicka J
J Med Chem; 1998 Dec; 41(26):5257-64. PubMed ID: 9857093
[TBL] [Abstract][Full Text] [Related]
17. A novel X-ray powder diffractometric method for studying the reaction between pseudoephedrine enantiomers.
Duddu SP; Khin-Khin A; Grant DJ; Suryanarayanan R
J Pharm Sci; 1997 Mar; 86(3):340-5. PubMed ID: 9050803
[TBL] [Abstract][Full Text] [Related]
18. Preferential enrichment: full crystallographic analysis of the unusual phenomenon in the mixed crystals' version.
Takahashi H; Tamura R; Fujimoto D; Lepp Z; Kobayashi K; Ushio T
Chirality; 2002 Jul; 14(7):541-7. PubMed ID: 12112325
[TBL] [Abstract][Full Text] [Related]
19. Effects of configuration around the chiral carbon atoms on the crystal properties of ephedrinium and pseudoephedrinium salicylates.
Duddu SP; Grant DJ
Pharm Res; 1994 Nov; 11(11):1549-56. PubMed ID: 7870670
[TBL] [Abstract][Full Text] [Related]
20. A new polymorphic form of metoprolol succinate.
Zhou M; Ao J; Liu S; Wu C; Lai A; Gao H; Zhang G
Pharm Dev Technol; 2017 Feb; 22(1):58-62. PubMed ID: 26906168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
